A detailed history of Fortis Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fortis Advisors, LLC holds 2,083 shares of MRK stock, worth $263,395. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,083
Previous 3,300 36.88%
Holding current value
$263,395
Previous $359,000 23.68%
% of portfolio
0.21%
Previous 0.29%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $137,813 - $160,583
-1,217 Reduced 36.88%
2,083 $274,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $76,027 - $82,866
-700 Reduced 17.5%
3,300 $380,000
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $34,826 - $39,123
-412 Reduced 9.34%
4,000 $344,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $7,764 - $8,801
93 Added 2.15%
4,412 $402,000
Q3 2021

Nov 23, 2021

SELL
$71.68 - $78.83 $10.3 Million - $11.3 Million
-143,944 Reduced 97.09%
4,319 $324,000
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $10.3 Million - $11.4 Million
144,180 Added 3531.23%
148,263 $468,000
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $52,029 - $57,549
-740 Reduced 15.34%
4,083 $318,000
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $125,531 - $147,863
1,823 Added 60.77%
4,823 $372,000
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $131,724 - $149,310
-1,800 Reduced 37.5%
3,000 $249,000
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $32,322 - $36,779
-459 Reduced 8.73%
4,800 $371,000
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $1,457 - $2,019
23 Added 0.44%
5,259 $405,000
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $17,954 - $19,571
236 Added 4.72%
5,236 $442,000
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $5,769 - $6,784
-100 Reduced 1.96%
5,000 $355,000
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $5,162 - $6,164
-100 Reduced 1.92%
5,100 $287,000
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $305,084 - $328,276
5,200
5,200 $333,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fortis Advisors, LLC Portfolio

Follow Fortis Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Advisors, LLC with notifications on news.